The information in this section is intended for visitors outside the United States.
The Chronicle of Philanthropy ranked Gilead first among companies in charitable giving and second overall on a list that includes some of the largest companies in the United States. Overall rankings included both charitable giving and in-kind donations.
In 2015, Gilead donated almost $500 million to organizations around the world that are working to improve the lives of people living with life-threatening diseases. Gilead’s corporate giving programs support organizations across the company’s therapeutic areas with the goal of improving access to healthcare, eliminating health disparities, and advancing education among healthcare providers and patients.
“Gilead is honored to receive this recognition from The Chronicle of Philanthropy,” says Gregg Alton, executive vice president, Commercial and Access Operations ALA, Corporate and Medical Affairs. “We are humbled by the stories of impact our giving programs have on individuals around the world.”
Private funding from corporate partners including Gilead plays a key role for organizations such as the National Viral Hepatitis Roundtable, for example. Funding Gilead provided last year has been critical to an Institute of Medicine report that the NVHR has commissioned with the U.S. Centers for Disease Control and Prevention and other organizations. The goal of the report is to identify specific goals and strategies for the United States to one day eliminate hepatitis B and hepatitis C.
Developing World Access